Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

Jesus D. Anampa Mesias, Tamanna Haque, Irina Murakhovskaya, Yanhua Wang, Kimo Bachiashvili, Cristian Papazoglu, Kith Pradhan, Ulrich G. Steidl, Joseph A. Sparano, Amit K. Verma

Research output: Contribution to journal › Letter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)e98-e102
JournalHaematologica
Volume103
Issue number3
DOIs
StatePublished - Feb 28 2018

Fingerprint

Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Anemia
Breast Neoplasms
palbociclib

ASJC Scopus subject areas

  • Hematology

Cite this

Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer. / Anampa Mesias, Jesus D.; Haque, Tamanna; Murakhovskaya, Irina; Wang, Yanhua; Bachiashvili, Kimo; Papazoglu, Cristian; Pradhan, Kith; Steidl, Ulrich G.; Sparano, Joseph A.; Verma, Amit K.

In: Haematologica, Vol. 103, No. 3, 28.02.2018, p. e98-e102.

Research output: Contribution to journal › Letter

Anampa Mesias, JD, Haque, T, Murakhovskaya, I, Wang, Y, Bachiashvili, K, Papazoglu, C, Pradhan, K, Steidl, UG, Sparano, JA & Verma, AK 2018, 'Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer', Haematologica, vol. 103, no. 3, pp. e98-e102. https://doi.org/10.3324/haematol.2017.181941
Anampa Mesias JD, Haque T, Murakhovskaya I, Wang Y, Bachiashvili K, Papazoglu C et al. Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer. Haematologica. 2018 Feb 28;103(3):e98-e102. https://doi.org/10.3324/haematol.2017.181941
Anampa Mesias, Jesus D. ; Haque, Tamanna ; Murakhovskaya, Irina ; Wang, Yanhua ; Bachiashvili, Kimo ; Papazoglu, Cristian ; Pradhan, Kith ; Steidl, Ulrich G. ; Sparano, Joseph A. ; Verma, Amit K. / Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer. In: Haematologica. 2018 ; Vol. 103, No. 3. pp. e98-e102.
@article{b85dcaf8198a4f89b6f494a68f5cf25d,
title = "Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer",
author = "{Anampa Mesias}, {Jesus D.} and Tamanna Haque and Irina Murakhovskaya and Yanhua Wang and Kimo Bachiashvili and Cristian Papazoglu and Kith Pradhan and Steidl, {Ulrich G.} and Sparano, {Joseph A.} and Verma, {Amit K.}",
year = "2018",
month = "2",
day = "28",
doi = "10.3324/haematol.2017.181941",
language = "English (US)",
volume = "103",
pages = "e98--e102",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "3",

}

TY - JOUR

T1 - Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

AU - Anampa Mesias, Jesus D.

AU - Haque, Tamanna

AU - Murakhovskaya, Irina

AU - Wang, Yanhua

AU - Bachiashvili, Kimo

AU - Papazoglu, Cristian

AU - Pradhan, Kith

AU - Steidl, Ulrich G.

AU - Sparano, Joseph A.

AU - Verma, Amit K.

PY - 2018/2/28

Y1 - 2018/2/28

UR - http://www.scopus.com/inward/record.url?scp=85042632788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042632788&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.181941

DO - 10.3324/haematol.2017.181941

M3 - Letter

VL - 103

SP - e98-e102

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 3

ER -

Access to Document